Abstract
The objective of present investigation was to develop and evaluate Nanoparticulate Periodontal Drug Delivery System (NPDDS) for local delivery of metronidazole benzoate with combination processing method. Dichloromethane, acetone and ethanol were utilized in combination with, HPMC E15 LV, HPC LF and gelusire 44/14, formulation stabilizers to develop NPDDS. A specific DOE was selected to study the effects and interactions of stabilizers and solvent mixture on particle size distribution and other relevant formulation characterization parameters. We have considered four independent variables X1, X2, X3 and Z4 are HPMC E15 LV, (HPC-LF), Gelusire 44/14 and Solvent mixture, respectively. DOE was used in this investigation to map the system and thus to approximate the Mean particle size (MPS) (Y1), Drug release at 30 minute (%) (Y(30 min)) (Y2), and time for 50% drug release [t50%] (Y3) to find an optimal range of experimental conditions. A two step production process, including combination of high speed homogenization and wet media milling technique was developed. Formulation stabilizer gelusire 44/14 has shown prominent effect over MPS, Y(30 min), and t50%. Overall effect of factors over the responses is graphically represented by the ternary plots.
Keywords: Design of experiment, gelusire 44/14, metronidazole benzoate, nanoparticulate drug delivery, periodontitis.
Graphical Abstract
Micro and Nanosystems
Title:Formulation Development of Nanoparticulate Periodontal Drug Delivery System of Metronidazole Benzoate with Combination Processing Method by Using Design of Experiment
Volume: 7 Issue: 1
Author(s): Mahesh R. Dabhi and Navin R. Sheth
Affiliation:
Keywords: Design of experiment, gelusire 44/14, metronidazole benzoate, nanoparticulate drug delivery, periodontitis.
Abstract: The objective of present investigation was to develop and evaluate Nanoparticulate Periodontal Drug Delivery System (NPDDS) for local delivery of metronidazole benzoate with combination processing method. Dichloromethane, acetone and ethanol were utilized in combination with, HPMC E15 LV, HPC LF and gelusire 44/14, formulation stabilizers to develop NPDDS. A specific DOE was selected to study the effects and interactions of stabilizers and solvent mixture on particle size distribution and other relevant formulation characterization parameters. We have considered four independent variables X1, X2, X3 and Z4 are HPMC E15 LV, (HPC-LF), Gelusire 44/14 and Solvent mixture, respectively. DOE was used in this investigation to map the system and thus to approximate the Mean particle size (MPS) (Y1), Drug release at 30 minute (%) (Y(30 min)) (Y2), and time for 50% drug release [t50%] (Y3) to find an optimal range of experimental conditions. A two step production process, including combination of high speed homogenization and wet media milling technique was developed. Formulation stabilizer gelusire 44/14 has shown prominent effect over MPS, Y(30 min), and t50%. Overall effect of factors over the responses is graphically represented by the ternary plots.
Export Options
About this article
Cite this article as:
Dabhi R. Mahesh and Sheth R. Navin, Formulation Development of Nanoparticulate Periodontal Drug Delivery System of Metronidazole Benzoate with Combination Processing Method by Using Design of Experiment, Micro and Nanosystems 2015; 7 (1) . https://dx.doi.org/10.2174/1876402907666150421230046
DOI https://dx.doi.org/10.2174/1876402907666150421230046 |
Print ISSN 1876-4029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-4037 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anatomical and Functional Relationships Between Sensory Nerves and Mast Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Electrochemical Study of DNA Damaged by Oxidation Stress
Combinatorial Chemistry & High Throughput Screening Effect of Different Derivatives of Shikonin from Lithospermum erythrorhizon Against the Pathogenic Dental Bacteria
Current Pharmaceutical Analysis Stem Cells as a Novel Tool for Drug Screening and Treatment of Degenerative Diseases
Current Pharmaceutical Design Risk Factors, Mechanisms and Treatments of Thromboangiitis Obliterans: An Overview of Recent Research
Current Medicinal Chemistry The Use of Phages for the Removal of Infectious Biofilms
Current Pharmaceutical Biotechnology MiR-106a Associated with Diabetic Peripheral Neuropathy Through the Regulation of 12/15-LOX-meidiated Oxidative/Nitrative Stress
Current Neurovascular Research MiRNAs in Bone Diseases
MicroRNA Suppression of Virulence of Porphyromonas gingivalis by Potent Inhibitors Specific for Gingipains
Current Protein & Peptide Science Ofloxacin Loaded Electrospun Fibers for Ocular Drug Delivery: Effect of Formulation Variables on Fiber Morphology and Drug Release
Current Drug Delivery Regenerative Medicine in Retina: The Future Cure
Current Tissue Engineering (Discontinued) Does It Make Sense that Diabetes is Reciprocally Associated with Periodontal Disease?
Endocrine, Metabolic & Immune Disorders - Drug Targets Growth Factor Delivery to Re-Engineer Periodontal Tissues
Current Pharmaceutical Biotechnology Challenges and Advances in Infection Control of Hematopoietic Stem Cell Transplant Recipients
Infectious Disorders - Drug Targets Protective Effects of Curcumin against Lipopolysaccharide-Induced Toxicity
Current Medicinal Chemistry Low Level Laser Therapy [LLLT] in Inflammatory and Rheumatic Diseases:A Review of Therapeutic Mechanisms
Current Rheumatology Reviews Probiotics in Intestinal and Non-Intestinal Infectious Diseases – Clinical Evidence
Current Pharmaceutical Design Do Epigenetic Marks Govern Bone Mass and Homeostasis?
Current Genomics Cell Therapy Using Induced Pluripotent Stem Cells or Somatic Stem Cells: This is the Question
Current Stem Cell Research & Therapy Models of Infection Before and After Stroke: Investigating New Targets
Infectious Disorders - Drug Targets